Additionally, 11–40% of IPAH patients without a family history also harbor BMPR-II mutations, highlighting the significant role of BMP signaling in PAH pathogenesis (272, 273). The gene discussed is BMPR2; the disease is idiopathic pulmonary arterial hypertension.